BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 20620398)

  • 1. Aberrant methylated key genes of methyl group metabolism within the molecular etiology of urothelial carcinogenesis.
    Erichsen L; Ghanjati F; Beermann A; Poyet C; Hermanns T; Schulz WA; Seifert HH; Wild PJ; Buser L; Kröning A; Braunstein S; Anlauf M; Jankowiak S; Hassan M; Bendhack ML; Araúzo-Bravo MJ; Santourlidis S
    Sci Rep; 2018 Feb; 8(1):3477. PubMed ID: 29472622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic Regulation in Urothelial Carcinoma.
    Li K; Qi L; Tang G; Xu H; Li Z; Fan B; Li Z; Li Y
    Curr Mol Med; 2024; 24(1):85-97. PubMed ID: 36545729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial Comment on Epigenetic alterations in urothelial bladder cancer associated with disease outcomes.
    Arai S
    Int J Urol; 2024 Mar; 31(3):229-230. PubMed ID: 38071741
    [No Abstract]   [Full Text] [Related]  

  • 4. Changes in Apoptotic Pathways in MOLM-13 Cell Lines after Induction of Resistance to Hypomethylating Agents.
    Janotka Ľ; Messingerová L; Šimoničová K; Kavcová H; Elefantová K; Sulová Z; Breier A
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Not Available].
    Bouzouita A; Saadi A; Kerkeni W; Chakroun M; Cherif M; Ayed H; Selmi S; Derouiche A; Benslama RM; Chebil M
    Can Urol Assoc J; 2016; 10(3-4):E110-3. PubMed ID: 27330577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TERT Core Promotor Mutations in Early-Onset Bladder Cancer.
    Giedl J; Rogler A; Wild A; Riener MO; Filbeck T; Burger M; Rümmele P; Hurst C; Knowles M; Hartmann A; Zinnall U; Stoehr R
    J Cancer; 2016; 7(8):915-20. PubMed ID: 27313781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presentation of case: Bladder cancer in an 18 year old female patient.
    Sheehan L; Anwar A; Kommu S
    Int J Surg Case Rep; 2015; 7C():42-6. PubMed ID: 25574770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urothelial tumors of the urinary bladder in young patients: a clinicopathologic study of 59 cases.
    Stanton ML; Xiao L; Czerniak BA; Guo CC
    Arch Pathol Lab Med; 2013 Oct; 137(10):1337-41. PubMed ID: 24079760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation-based biomarkers in bladder cancer.
    Kandimalla R; van Tilborg AA; Zwarthoff EC
    Nat Rev Urol; 2013 Jun; 10(6):327-35. PubMed ID: 23628807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypermethylation in bladder cancer: biological pathways and translational applications.
    Sánchez-Carbayo M
    Tumour Biol; 2012 Apr; 33(2):347-61. PubMed ID: 22274923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environmental chemical exposures and human epigenetics.
    Hou L; Zhang X; Wang D; Baccarelli A
    Int J Epidemiol; 2012 Feb; 41(1):79-105. PubMed ID: 22253299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma.
    Catto JW; Azzouzi AR; Rehman I; Feeley KM; Cross SS; Amira N; Fromont G; Sibony M; Cussenot O; Meuth M; Hamdy FC
    J Clin Oncol; 2005 May; 23(13):2903-10. PubMed ID: 15753461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypermethylation of the polycomb group target gene PCDH7 in bladder tumors from patients of all ages.
    Beukers W; Hercegovac A; Vermeij M; Kandimalla R; Blok AC; van der Aa MM; Zwarthoff EC; Zuiverloon TC
    J Urol; 2013 Jul; 190(1):311-6. PubMed ID: 23369722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for the early onset of aberrant promoter methylation in urothelial carcinoma.
    Dhawan D; Hamdy FC; Rehman I; Patterson J; Cross SS; Feeley KM; Stephenson Y; Meuth M; Catto JW
    J Pathol; 2006 Jul; 209(3):336-43. PubMed ID: 16639696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular changes in development and progression of urothelial carcinoma].
    Hartmann A
    Verh Dtsch Ges Pathol; 2003; 87():172-84. PubMed ID: 16888910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low frequency of epigenetic events in urothelial tumors in young patients.
    Owen HC; Giedl J; Wild PJ; Fine SW; Humphrey PA; Dehner LP; Amin MB; Epstein JI; Blaszyk H; Hughes D; Hartmann A; Stoehr R; Catto JW
    J Urol; 2010 Aug; 184(2):459-63. PubMed ID: 20620398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urothelial neoplasms of the urinary bladder occurring in young adult and pediatric patients: a comprehensive review of literature with implications for patient management.
    Paner GP; Zehnder P; Amin AM; Husain AN; Desai MM
    Adv Anat Pathol; 2011 Jan; 18(1):79-89. PubMed ID: 21169741
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.